Biography
Guy H Fontaine has made 17 original contributions in the design and the use of the first cardiac pace makers in the early 60s. He has serendipitously identified ARVD during his contributions to antiarrhythmic surgery in the early 70s. He has developed the technique of Fulguration to replace surgery in the early 80s (technique used during 30 years in Paris). He has been one of the 216 individuals who have made a significant contribution to the study of cardiovascular disease since the 14th century, one of the 500 greatest geniuses of the 21th Century (USA Books), one of the 100 Life Time Achievement (UK Book). He has more than 900 publications including 201 chapters in text books. He is the reviewer of 26 scientific journals both in basic and clinical science. He served as a member of the Editorial Board of Circulation for 5 years, after reviewing articles for this journal during decades. He has given 11 master lectures of 90 minutes each in inland China in 2014. He has recently developed new techniques of hypothermia for brain protection in OHCA and Stroke. This technique has been fortuitously used after resuscitation of his wife at home in June 2011 with absolutely no neurologic deficit despite 6 minutes of no flow. He has also invented a high-tech device which can be considered the ultimate in palliative care by preventing unexpectedly awaking after ordinary sleep. This device was mostly designed for major neurologic disorders. To know more about him introduce his full name on Google “Guy Hugues Fontaineâ€. His main lectures for the year 2016 have been in Cardiology and Neurology in: London, Dubai, Berlin, Baltimore, Philadelphia, Las Vegas, Tucson, Miami and Dubai again.
Research Interest
Parkinson Disease
Jean Barclay
Manager
Global Clinical Development and Regulatory Affairs at Luye Pharma Group Ltd
USA
Biography
Jean has over 12 years of experience in the Clinical Operations and Regulatory Affairs area of Clinical Research. She is a knowledgeable clinical research professional and her career path has given her well-rounded experience in Drug, Device and Biologic research, in addition to overseeing and performing clinical operations. Her credentials include a BS in Business, MS in Clinical Research Administration, proficiencies in generally accepted research practices (GCP, ICH and FDA Code of Federal Regulations) as well as management and leadership skill sets. During her career, Jean has worked on trials in the United States (US), Japan, China, Europe and South America. Her extensive experience includes the Clinical Research Organization (CRO) and Pharmaceutical side of research as well as the Regulatory Affairs side including Investigational New Drug (IND) Submissions and meetings with Federal Drug Administration (FDA).
Research Interest
Clinical Trials
Junxia Xie
Director
Shandong Provincial Collaborative Innovation Center for Neurodegenerative Disorders
China
Biography
Junxia Xie is Taishan scholar distinguished professor. She is currently the director of Shandong Provincial Collaborative Innovation Center for Neurodegenerative Disorders. She is also the vice president of Qingdao University, the vice president of Chinese Association of Physiological Sciences as well as Chinese Neuroscience Society. Her research mainly focuses on the pathogenesis and therapeutic strategies for neurodegenerative diseases, especially the role of iron imbalance and its contributions to nigral dopaminergic neurons degeneration in Parkinson’s disease. She has published 150 articles up to now, including Nature Communications, Neurology, Cell Research etc.
Research Interest
Neurodegenerative Diseases
